1. Home
  2. BHAT vs BCDA Comparison

BHAT vs BCDA Comparison

Compare BHAT & BCDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BHAT
  • BCDA
  • Stock Information
  • Founded
  • BHAT 2010
  • BCDA N/A
  • Country
  • BHAT China
  • BCDA United States
  • Employees
  • BHAT N/A
  • BCDA N/A
  • Industry
  • BHAT Recreational Games/Products/Toys
  • BCDA Biotechnology: Pharmaceutical Preparations
  • Sector
  • BHAT Consumer Discretionary
  • BCDA Health Care
  • Exchange
  • BHAT Nasdaq
  • BCDA Nasdaq
  • Market Cap
  • BHAT 12.3M
  • BCDA 11.3M
  • IPO Year
  • BHAT 2019
  • BCDA N/A
  • Fundamental
  • Price
  • BHAT $1.77
  • BCDA $1.70
  • Analyst Decision
  • BHAT
  • BCDA Strong Buy
  • Analyst Count
  • BHAT 0
  • BCDA 1
  • Target Price
  • BHAT N/A
  • BCDA $25.00
  • AVG Volume (30 Days)
  • BHAT 1.1M
  • BCDA 46.4K
  • Earning Date
  • BHAT 04-30-2025
  • BCDA 11-12-2025
  • Dividend Yield
  • BHAT N/A
  • BCDA N/A
  • EPS Growth
  • BHAT N/A
  • BCDA N/A
  • EPS
  • BHAT N/A
  • BCDA N/A
  • Revenue
  • BHAT $18,724,190.00
  • BCDA N/A
  • Revenue This Year
  • BHAT N/A
  • BCDA N/A
  • Revenue Next Year
  • BHAT N/A
  • BCDA N/A
  • P/E Ratio
  • BHAT N/A
  • BCDA N/A
  • Revenue Growth
  • BHAT N/A
  • BCDA N/A
  • 52 Week Low
  • BHAT $1.51
  • BCDA $1.63
  • 52 Week High
  • BHAT $45.00
  • BCDA $3.25
  • Technical
  • Relative Strength Index (RSI)
  • BHAT 54.51
  • BCDA 34.30
  • Support Level
  • BHAT $1.62
  • BCDA $2.11
  • Resistance Level
  • BHAT $2.02
  • BCDA $2.29
  • Average True Range (ATR)
  • BHAT 0.17
  • BCDA 0.11
  • MACD
  • BHAT 0.01
  • BCDA -0.00
  • Stochastic Oscillator
  • BHAT 44.44
  • BCDA 1.65

About BHAT Blue Hat Interactive Entertainment Technology

Blue Hat Interactive Entertainment Technology is focused on commodity trading, including chemicals, jewelry, and precious metals such as gold. It operates a gold and diamond trading and supply chain business. Its business model encompasses physical gold trading, diamond trading, gold derivatives trading, and the development of AI-enabled trading platforms. Its segments include Diamond trading, Commodity trading, Information service, Interactive toys - animation series, and Interactive toys - game series. It derives revenue from Diamond trading. The majority of its revenues are generated in PRC.

About BCDA BioCardia Inc.

BioCardia Inc is a clinical-stage company developing cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases with unmet medical needs. Its two cell therapy platforms derived from the bone marrow. CardiAMP autologous mononuclear cell therapy platform is being advanced for two clinical indications: ischemic heart failure with reduced ejection fraction (HFrEF) and refractory angina resulting from chronic myocardial ischemia (CMI). Its immunomodulatory allogeneic mesenchymal stem cell (MSC) therapy platform is being an off the shelf cell therapy for two clinical indications: the treatment of ischemic HFrEF (CardiALLO), which is actively enrolling, and acute respiratory distress syndrome (ARDS).

Share on Social Networks: